An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Clinical trial NCT01467505 · TERMINATED
Trial details
- NCT number
- NCT01467505
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-04-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.